The global medical radiation shielding market is expected to reach $1,360.0 million by 2027 from $998.2 million in 2020, at a CAGR of 6.9%. Some of the key factors influencing the market growth include increase in the prevalence of chronic diseases, rise in safety awareness among the healthcare professionals, rise in number of diagnostic centers, and development in healthcare infrastructure anticipated to bolster the medical radiation shielding market over the forecast years. Medical radiation shielding products aid in the protection of humans from dangerous radiation exposure. Gamma and x-rays are also stopped by medical radiation shielding products. Traditional lead (Pb) shielding, lead (Pb) composite shielding, non-lead (Pb), and lead (Pb) free shielding are three different types of radiation shielding materials that all play a significant role in radiation protection. The rise in the number of diagnostic imaging centres and installations, as well as increased safety awareness among workers handling radioactive equipment, is a key driver driving market expansion. Furthermore, in the anticipated period of 2021 to 2027, an increase in the growth potential of emerging nations would generate additional chances for the medical radiation shielding market. However, among other things, a scarcity of qualified professionals and the high cost of MRI systems are important barriers that would stifle the growth of the global market over the forecast period.